Connecticut Firefighters Sue Major Corporations Over Gear Safety by Mark Eisenberg 26.06.2024 Connecticut firefighters sue DuPont, 3M, and Honeywell over cancer-causing PFAS in gear. Learn about the health risks and lawsuit details.
UnityPoint’s Neoprobe Technology Enhances Cancer Surgery Outcomes by Lilu Anderson 26.06.2024 UnityPoint Health-Grinnell introduces Neoprobe Gamma Detection for precise breast cancer surgery, enhancing patient care and personalized treatment.
AI in Medical Diagnostics Market to Hit $30.76B by 2032, Led by Software by Lilu Anderson 25.06.2024 "AI in Medical Diagnostics set to skyrocket to USD 30.76 billion by 2032, driven by rapid advancements and major industry ...
Alnylam’s HELIOS-B Review: Conflicting Insights Analyzed by Lilu Anderson 25.06.2024 Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.
AI in Ultrasound Imaging Market to Hit $1733M by 2031 by Lilu Anderson 25.06.2024 Artificial Intelligence in Ultrasound Imaging Market to grow from USD 889.16 million in 2023 to USD 1733.08 million by 2031 ...
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cut by Mark Eisenberg 20.06.2024 Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...
Iontronic Tech Promises Hope in Slowing Malignant Brain Tumors by Lilu Anderson 20.06.2024 "Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
Front Page Drama: Tax Dossier, IT Crisis, and Sunak’s Voyages by Mark Eisenberg 19.06.2024 Discover how major UK newspapers are reacting to Labour's "secret tax rise" plans, including insights on financial, political, and health ...
Day One Biopharma Expands to ADCs with $55M Drug Acquisition by Lilu Anderson 19.06.2024 "Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."
J&J Faces New Class Action: Medical Monitoring for Talc Users by Mark Eisenberg 19.06.2024 Johnson & Johnson faces a new class action lawsuit for talc products, demanding medical monitoring for cancer risk while opposing ...